Sai Parenteral's

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0H9F01037
  • NSEID: SAIPARENT
  • BSEID: 544742
INR
475.65
2.7 (0.57%)
BSENSE

May 20

BSE+NSE Vol: 9.55 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

9.55 k (-69.33%) Volume

Shareholding (Apr 2026)

FII

5.73%

Held by 9 FIIs

DII

12.86%

Held by 6 DIIs

Promoter

51.16%

Which are the latest news on Sai Parenteral's?

19-May-2026
No latest news for Sai Parenteral's found.

Why is Sai Parenterals Ltd falling/rising?

20-May-2026

As of 19-May, Sai Parenterals Ltd's stock price is at 472.95, reflecting a decline of 1.3% and part of a broader trend of underperformance. The stock has shown short-term weakness with decreased investor participation and consecutive losses over the past two days.

As of 19-May, Sai Parenterals Ltd's stock price is falling, currently at 472.95, which reflects a decrease of 6.25 or 1.3%. This decline is part of a broader trend, as the stock has underperformed its sector by 1.93% today and has experienced consecutive losses over the last two days, totaling a drop of 1.92%. <BR><BR>In terms of performance relative to the market, the stock has shown a slight increase of 0.38% over the past week, but it has decreased by 1.12% over the past month, contrasting with the Sensex, which has fallen by 4.19% in the same timeframe. Despite being higher than the 50-day, 100-day, and 200-day moving averages, the stock is lower than its 5-day and 20-day moving averages, indicating a short-term weakness.<BR><BR>Additionally, there has been a notable decline in investor participation, with delivery volume dropping by 13.99% compared to the 5-day average. This reduced activity may contribute to the stock's downward pressure. Overall, these factors indicate that Sai Parenterals Ltd is currently facing challenges that are leading to its falling stock price.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 2,101 Cr (Small Cap)

stock-summary
P/E

202.00

stock-summary
Industry P/E

35

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.77

stock-summary
Return on Equity

11.32%

stock-summary
Price to Book

22.87

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Monitoring Agency Report

13-May-2026 | Source : BSE

Monitoring Agency Report

Results-Delay in Financial Results

22-Apr-2026 | Source : BSE

Results- Delay in financial Results

Board Meeting Outcome for Outcome Of Board Meeting

20-Apr-2026 | Source : BSE

Outcome of Board Meeting

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
2.71
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
28.14%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
18.59%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
202
Industry P/E
35
Price to Book Value
22.87
EV to EBIT
100.64
EV to EBITDA
80.14
EV to Capital Employed
13.33
EV to Sales
17.38
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
13.24%
ROE (Latest)
11.32%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
No Trend
OBV
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Apr 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (3.81%)

FIIs

Held by 9 FIIs (5.73%)

Promoter with highest holding

Vijitha Gorrepati (0.29%)

Highest Public shareholder

Quant Mutual Fund - Quant Small Cap Fund (0.038%)

Individual Investors Holdings

22.67%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Sai Parenteral's"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Sai Parenteral's"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Sai Parenteral's"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "124.27",
          "val2": "113.89",
          "chgp": "9.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "26.95",
          "val2": "21.47",
          "chgp": "25.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.31",
          "val2": "6.17",
          "chgp": "18.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "10.34",
          "val2": "7.16",
          "chgp": "44.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.69%",
          "val2": "18.85%",
          "chgp": "2.84%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
124.27
113.89
9.11%
Operating Profit (PBDIT) excl Other Income
26.95
21.47
25.52%
Interest
7.31
6.17
18.48%
Exceptional Items
0.00
0.00
Standalone Net Profit
10.34
7.16
44.41%
Operating Profit Margin (Excl OI)
21.69%
18.85%
2.84%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Sai Parenterals Ltd stock-summary
stock-summary
Sai Parenterals Ltd
Small Cap
Pharmaceuticals & Biotechnology
Sai Parenteral's Limited was originally incorporated as `Sai Parenteral's Private Limited', a Private Limited Company on January 12, 2001, with the Registrar of Companies, at Hyderabad. Thereafter, Company was converted into a Public Limited Company and the name of Company was changed to `Sai Parenteral's Limited' w.e.f January 17, 2022.
Company Coordinates stock-summary
Icon
No Company Details Available